UIA
NEUE

Ulland Investment Advisors’s NeueHealth NEUE Stock Holding History

Ulland Investment Advisors’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4
Closed – – 229
2022
Q3 		$0 Hold
4
– – ﹤0.01% 251
2022
Q2 		$1K Hold
4
– – ﹤0.01% 241
2022
Q1 		$1K Hold
4
– – ﹤0.01% 258
2021
Q4 		$1K Buy
+4
New +$1.85K ﹤0.01% 213

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ulland Investment Advisors's NEUE Position: Q4 2022 in Review

Ulland Investment Advisors sold out of NeueHealth (NEUE) in Q4 2022, closing a stake of 4 shares.

Ulland Investment Advisors first reported a position in NEUE in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q2 2022. 127 funds tracked by Wall St. Rank hold NEUE as of Q4 2022.

  • Ulland Investment Advisors reported no remaining NeueHealth position as of Q4 2022 after selling out during the quarter.
  • Ulland Investment Advisors sold 4 NeueHealth shares in Q4 2022.
  • Ulland Investment Advisors first reported a position in NeueHealth in Q4 2021 and held it in 4 quarters.
  • Ulland Investment Advisors's NeueHealth position peaked at $1K in Q2 2022.
  • 127 funds tracked by Wall St. Rank held NeueHealth as of Q4 2022.

Based on Ulland Investment Advisors's 13F filing for Q4 2022, filed 31 Jan 2023.